The severity of clinical symptoms in ragweed-allergic patients is related to the extent of ragweed-induced complement activation in their sera

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 52, Issue 11, 1997, Pages 1110-1114

  Gonczi Zs ^a   Varga, L ^b   Hidvegi T ^b,d   Schmidt, B ^b   Panya A ^b   Kokai M ^b   Fust G ^c,d  

^a Outpatient Dept Resp Allergic Dis   (Hungary)

^b National Institute of Haematology and Immunology Budapest   (Hungary)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Allergen; C3a; C5a; Complement; Complement activation; Ragweed

Indexed keywords

COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; RAGWEED ANTIGEN;

ADOLESCENT; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ALLERGY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LARYNGITIS; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SCORING SYSTEM; SKIN TEST;

EID: 0030659142     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1997.tb00184.x     Document Type: Article

References (15)

1. Hidvégi T, Schmidt B, Varga L, et al. In vitro complement activation by ragweed allergen extract in the sera of ragweed allergic allergic and non-allergic persons. Immunol Lett 1995;48:65-71.
2. Nielsson T, Back O. Determination of C1s-C1 inhibitor complexes in plasma by means of an enzyme linked immunosorbent assay. Clin Exp Immunol 1985;60:178-82.
3. Zilow G, Sturm A, Rother U, Kirschfink M. Complement activation and the prognostic value of C3a in patients at risk of adult respiratory distress syndrome. Clin Exp Immunol 1990;79:151-7.
4. Deppish R, Schmitt V, Bommer J, Hannsch M, Ritz E, Rautenberg EW. Fluid phase generation of terminal complement complex as a novel index of biocompatibility. Kidney Int 1990;37:696-706.
5. Nagata S, Glovsky M. Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation. J Allergy Clin Immunol 1987;80:24-32.
6. Weemaes CMR, Stoop JW, Berrens L. Inactivation of haemolytic complement by house-dust allergen in the serum of children with atopic diseases. Clin Allergy 1977;7:75-82.
7. Pryjma JR, Miklaszewska J, Haluszka J, Scislici A. Decrease of complement haemolytic activity after an allergenhouse dust bronchial provocation test. J Allergy Clin Immunol 1982;70:306-12.
8. Varga L, Dervaderics M, Zsiray M, Kárpáthy J, Füst G. Granulocyte aggregating activity in sera of workers exposed to textile dust inhalation. Diagn Immunol 1986; 4:140-4.
9. Ballow M, Donshik PC, Mendelson L. Complement proteins and C3 anaphylatoxin in the tears of patients with conjunctivitis. J Allergy Clin Immunol 1985;76:473-6.
10. Andersson M, Michel L, Llull JB, Pipkorn U. Complement activation on the nasal mucosal surface - a feature of the immediate allergic reaction in the nose. Allergy 1994;49:242-5.
11. Fraser DG, Regal JF, Arndt ML. Trimellitic anhydride-induced allergic response in the lung: role of the complement system in the cellular changes. J Pharmacol Exp Ther 1995;273:793-801.
12. Elsner J, Oppermann M, Czech W, et al. C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils. Eur J Immunol 1994;24:518-22.
13. Crouch S, Fleischer J. The priming effect of stimulated mononuclear cells on the response of neutrophils to C5a des arg. Br J Haematol 1991;74:158-64.
14. Carlson M, Peterson C, Venge P. The influence of IL-3, IL-5 and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation. Allergy 1993;48:437-42.
15. van der Zee JS, van Swieten P, Aalberse RC. Activation of the classical pathway of human complement in vitro by house-dust extracts is caused by IgM antibodies to polysaccharide antigen(s) and is not related to atopy. Mol Immunol 1988;25:345-54.